February 13, 2018
Keytruda Promising in PD-L1 Esophageal Cancer
CancerConnect News: The checkpoint inhibitor Keytruda (pembrolizumab) has been reported to produce an overall response rate of 30% in patients with PD-L1–positive, advanced esophageal cancer.1 About Keytruda Keytruda is a monoclonal antibody that helps to restore the body’s immune system in fighting cancer. It creates its anti-cancer effects by blocking a specific protein used by cancer […]
Tags: checkpoint inhibitor, Esophageal Cancer, gastroesophageal junction cancer, immunotherapy, keytruda, News Tips and Features, News Tips and Features Other, pembrolizumab, Precision Cancer Medicine
December 1, 2017
Diagnosed with Esophageal Cancer: 10 Tips on How to Get The Most From Your Doctor
1) Choose Your Doctor Carefully Surgeons, medical oncologists and radiation oncologists are the primary doctors involved with esophageal cancer and often work in collaboration. Pick your primary oncologist carefully, rely on people you trust including nurses and other health care professionals who make help with recommendations. Make sure your doctor is someone you feel comfortable […]
Tags: Esophageal Cancer, News Tips and Features, News Tips and Features Other
October 3, 2017
New Standard of Care for Treatment of Resectable Gastric Cancer
The superiority of docetaxel based triplet therapy over standard care in patients with resectable esophago-gastric cancer has been confirmed in late-breaking results from the FLOT4 trial presented at the ESMO 2017 Congress in Madrid.1 Survival in resectable esophago-gastric cancer is poor. Five-year overall survival is around 25% with surgery, and is increased to 36% by […]
Tags: Esophageal Cancer, esophago-gastric cancer, Gastric Cancer, News Tips and Features, News Tips and Features Other
September 25, 2017
Keytruda (Pembrolizumab) is now indicated for patients with recurrent locally advanced or metastatic gastric or gastro-esophogeal junction adenocarcinoma. Patients eligible for keytruda therapy under this new indication must have PD-L1-expressing tumors, and must demonstrate disease progression after two or more prior lines of therapy – including fluoropyrimidine- and platinum-containing chemotherapy and, in some cases, HER2/neu-targeted […]
Tags: checkpoint inhibitor, Esophageal Cancer, Gastric Cancer, gastro-esophogeal junction cancer, keytruda, metastatic gastric, News Tips and Features, News Tips and Features Other, pembrolizumab, Precision Cancer Medicine
June 27, 2017
Gerd- Raising Awareness About an Unknown Killer
By Sharon Reynolds ECAN spreads the word about the link between acid reflux and esophageal cancer. John Mordecai, better known to his many friends as Monte, was “a healthy guy,” remembers his wife, Mindy. He was a runner. He didn’t eat sugar and kept to a low-fat diet. But for many years, he experienced unexplained […]
Tags: Esophageal Cancer, GERD, News Tips and Features, News Tips and Features Other
February 9, 2017
Interim PET Scans May Improve Treatment for Esophageal Cancer
Clinical trial results presented at the 2017 Gastrointestinal Cancers Symposium in San Francisco suggest that the use of PET scans to assess a cancers response to initial chemotherapy may provide doctors with useful information to further tailor chemotherapy. Standard treatment of patients with stage II-III esophageal and gastroesophageal junction (GEJ) cancers includes chemotherapy with radiation […]
Tags: Esophageal Cancer, Gastric Cancer, News Tips and Features, News Tips and Features Other
January 23, 2017
Proton Beam Therapy May Improve Outcomes for Esophageal Cancer
Currently a standard treatment for several gastrointestinal cancers (GI) combines the use of chemotherapy and radiation followed by surgical resection. Radiation may be part of the treatment strategy for select cancers of the esophagus, anus, rectum, pancreatic, or small intestine. This treatment approach is often associated with improved outcomes but the radiation may also cause […]
Tags: Esophageal Cancer, Gastric Cancer, News Tips and Features, News Tips and Features Other, Pancreatic Cancer, proton beam therapy, Recurrent Gastric Cancer, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer, Stage IV/Recurrent Esophageal Cancer, Stages I-II Gastric Cancer, Stages I-III Esophageal Cancer
December 8, 2016
Should HER2 Testing Be Routinely Performed in Patients with Gastric Cancer?
The short answer is yes! New evidence-based guidelines for human epidermal growth factor receptor 2 (HER2) testing in advanced gastric and gastroesophageal adenocarcinoma (GEA) have been released jointly by the College of American Pathologists (CAP), American Society for Clinical Pathology (ASCP), and American Society of Clinical Oncology (ASCO). Currently, HER2 is the only marker that can be […]
Tags: adenocarcinoma, American Society for Clinical Pathology, and American Society of Clinical Oncology, asco, ASCP, CAP, College of American Pathologists, Esophageal Cancer, for human epidermal growth factor receptor 2, Gastric Cancer, Gastroesophageal cancer, HER2 testing
 |
 |
 |
